SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
184 8 0 SANG
Emcee:  Carson O. Ray, Jr. Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
84 Further conclusion: SANG is clearly undervalued!!!Darth Vader-2/17/1998
83 I'd suggest everyone do their own homework on PDLI/SANG. Mr. Sturges, for James Silverman-2/16/1998
82 Thymo is broadly use in Europe for treatment of rejection. The treatment of GEdeadstrait-2/16/1998
81 Thanks for you reply! Base on my research Zenapax's label is limited to indDarth Vader-2/14/1998
80 Gentlemen, the citations on the superior activity of Zenapax will begin to be aJohn S. Sturges-2/13/1998
79 I don't have time to provide a detailed response at this time, but here is pwrmstr-2/12/1998
78 Any feedback from you Roche contacts? Based on my info Sturges' posts are Darth Vader-2/12/1998
77 I believe Zenapax will be seen as a Cyclosporin replacement, the study was desiJohn S. Sturges-2/9/1998
76 John, regarding the Feb 18 meeting. My guess is that if there is new research bpwrmstr-2/8/1998
75 Thanks for correcting Sturges' mis-information. More specifically, Zenapaxpwrmstr-2/8/1998
74 John--- biz.yahoo.com JimJames Silverman-2/8/1998
73 My information is Thymoglobulin is 2-3yrs away from approval. It still needs a John S. Sturges-2/8/1998
72 John, Zenapax is approved for use in "combo" with cyclosporine. It iJames Silverman-2/8/1998
71 Red Flag!! PDLI's Zenapax is already approved(DEC '97) with no side-effJohn S. Sturges-2/8/1998
70 Great! Thymo news goes pretty much unnoticed. Patience required.Darth Vader-1/30/1998
69 < SANG is ready (Gensia, Abbot and Lilly I believe) to launche the product megazoo-1/26/1998
68 Fully agree with you and H&Q price targets - SANG is ready (Gensia, Abbot aDarth Vader-1/25/1998
67 Jay, FYI, H&Q's EPS estimate for 1999 is $2.00. So its 15X 1999 estimaJames Silverman-1/24/1998
66 Unfortunately I do not have time to build an in-depth model. However, to simpliDarth Vader-1/23/1998
65 Jim: Glad you were able to add. Don't get me wrong, I like the idea behinF. Jay Abella, III-1/23/1998
64 Jay A couple of things. The "recent product delays" are a bit miswoJames Silverman-1/23/1998
63 Hi All: I write this today. Would anyone here like to take a stab at modellinF. Jay Abella, III-1/23/1998
62 I agree with you SBX..this is probably the best buying opportunity on SANG in aDarth Vader-1/22/1998
61 hq has again cut sang. this analyst (rachel leahy, if she is the one) did the megazoo-1/22/1998
60 from Motley Fool Organ transplant therapies company Sangstat Medical (Nasdaq:Snelli-1/22/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News